Health Affairs, 28, no. 3 (2009): 724-733 doi: 10.1377/hlthaff.28.3.724 © 2009 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Busch, S. H. Articles by Barry, C. L. Search for Related Content PubMed PubMed Citation Articles by Busch, S. H. Articles by Barry, C. L. Related Collections Legal/Regulatory Issues Maternal And Child Health Mental Health/Substance Abuse Pharmaceuticals Consumer Issues Related Articles

Pharmaceuticals

Pediatric Antidepressant Use After The Black-Box Warning

In 2004 the Food and Drug Administration (FDA) required a black-box warning on antidepressants that describes a possible suicide risk in children. An analysis of the events, evidence, and FDA actions reveals information asymmetries that affect various players’ ability to identify and act on risks. Antidepressant use declined sharply overall, not just among children, and the FDA’s emphasis on the proven efficacy of fluoxetine (generic Prozac) did not prompt dramatic shifts in prescribing. We conclude that risk communication strategies need to be refined, to ensure intended results.

                      What's this?

Related Articles

• 
  Pharmaceuticals & Psychotropic Drugs
  Health Affairs, May/June 2009; 28(3): 723
  [Extract] [Full Text] [PDF]
   
  
• Haiden A. Huskamp, Alisa B. Busch, Marisa E. Domino, and Sharon-Lise T. Normand
  Antidepressant Reformulations: Who Uses Them, And What Are The Benefits?
  Health Affairs, May/June 2009; 28(3): 734-745.
  [Abstract] [Full Text] [PDF] [Appendix]
   
  
• Julie M. Donohue, Haiden A. Huskamp, and Samuel H. Zuvekas
  Dual Eligibles With Mental Disorders And Medicare Part D: How Are They Faring?
  Health Affairs, May/June 2009; 28(3): 746-759.
  [Abstract] [Full Text] [Figures Only] [PDF]